| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia
|
Alzubaidi, Hamzah
|
|
|
67 |
Suppl 1 |
p. 663-669
|
article
|
| 2 |
Accuracy of continuous glucose monitoring in the hospital setting: an observational study
|
O’Connor, Mollie Y.
|
|
|
67 |
Suppl 1 |
p. 2650-2659
|
article
|
| 3 |
Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men
|
Mäkinen, Selina
|
|
|
67 |
Suppl 1 |
p. 1943-1954
|
article
|
| 4 |
A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation
|
Villalba, Adrian
|
|
|
67 |
Suppl 1 |
p. 1066-1078
|
article
|
| 5 |
Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study
|
Cole, Andrew
|
|
|
67 |
Suppl 1 |
p. 2711-2725
|
article
|
| 6 |
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis
|
Chhabra, Kavaljit H.
|
|
|
67 |
Suppl 1 |
p. 170-189
|
article
|
| 7 |
Advances in diabetes technology to improve the lives of people with cystic fibrosis
|
Scully, Kevin J.
|
|
|
67 |
Suppl 1 |
p. 2143-2153
|
article
|
| 8 |
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
|
Mathieu, Chantal
|
|
|
67 |
Suppl 1 |
p. 27-41
|
article
|
| 9 |
Ageing well with diabetes: the role of technology
|
Maltese, Giuseppe
|
|
|
67 |
Suppl 1 |
p. 2085-2102
|
article
|
| 10 |
A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial
|
Monteyne, Alistair J.
|
|
|
67 |
Suppl 1 |
p. 1107-1113
|
article
|
| 11 |
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life
|
Vedovato, Natascia
|
|
|
67 |
Suppl 1 |
p. 940-951
|
article
|
| 12 |
Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight
|
Masalin, Senja
|
|
|
67 |
Suppl 1 |
p. 2539-2554
|
article
|
| 13 |
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study
|
Slieker, Roderick C.
|
|
|
67 |
Suppl 1 |
p. 885-894
|
article
|
| 14 |
A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes
|
Guo, Mengqi
|
|
|
67 |
Suppl 1 |
p. 623-640
|
article
|
| 15 |
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology
|
Matveyenko, Aleksey
|
|
|
67 |
Suppl 1 |
p. 1444-1445
|
article
|
| 16 |
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology. Reply to Matveyenko A, Vella A [letter]
|
Gandasi, Nikhil R.
|
|
|
67 |
Suppl 1 |
p. 1446-1447
|
article
|
| 17 |
Applying technologies to simplify strategies for exercise in type 1 diabetes
|
Perkins, Bruce A.
|
|
|
67 |
Suppl 1 |
p. 2045-2058
|
article
|
| 18 |
Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial
|
Molveau, Joséphine
|
|
|
67 |
Suppl 1 |
p. 2408-2419
|
article
|
| 19 |
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
|
Teixeira, Pedro F.
|
|
|
67 |
Suppl 1 |
p. 985-994
|
article
|
| 20 |
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study
|
Hurtado, Isabel
|
|
|
67 |
Suppl 1 |
p. 2471-2480
|
article
|
| 21 |
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort
|
Turner, Lauren V.
|
|
|
67 |
Suppl 1 |
p. 1009-1022
|
article
|
| 22 |
Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study
|
Fuhri Snethlage, Coco M.
|
|
|
67 |
Suppl 1 |
p. 1865-1876
|
article
|
| 23 |
Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data Infrastructure
|
Bowden, Nicholas
|
|
|
67 |
Suppl 1 |
p. 62-73
|
article
|
| 24 |
Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study
|
Brakenridge, Christian J.
|
|
|
67 |
Suppl 1 |
p. 1356-1367
|
article
|
| 25 |
Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study
|
Samuelsson, John
|
|
|
67 |
Suppl 1 |
p. 679-689
|
article
|
| 26 |
Bone metabolism in diabetes: a clinician’s guide to understanding the bone–glucose interplay
|
Sheu, Angela
|
|
|
67 |
Suppl 1 |
p. 1493-1506
|
article
|
| 27 |
Caesarean section and risk of type 1 diabetes
|
Singh, Tarini
|
|
|
67 |
Suppl 1 |
p. 1582-1587
|
article
|
| 28 |
Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England
|
Valabhji, Jonathan
|
|
|
67 |
Suppl 1 |
p. 1304-1314
|
article
|
| 29 |
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
|
Krishnan, Arunkumar
|
|
|
67 |
Suppl 1 |
p. 483-493
|
article
|
| 30 |
Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management
|
Eleftheriadou, Aikaterini
|
|
|
67 |
Suppl 1 |
p. 2611-2625
|
article
|
| 31 |
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study
|
ter Braake, Jonne G.
|
|
|
67 |
Suppl 1 |
p. 1029-1039
|
article
|
| 32 |
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes
|
Sridhar, Vikas S.
|
|
|
67 |
Suppl 1 |
p. 3-18
|
article
|
| 33 |
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank
|
Jin, Qiao
|
|
|
67 |
Suppl 1 |
p. 837-849
|
article
|
| 34 |
CK2 activity is crucial for proper glucagon expression
|
Ampofo, Emmanuel
|
|
|
67 |
Suppl 1 |
p. 1368-1385
|
article
|
| 35 |
Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study
|
Yuan, Shuai
|
|
|
67 |
Suppl 1 |
p. 1630-1641
|
article
|
| 36 |
Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes
|
Lenzen, Sigurd
|
|
|
67 |
Suppl 1 |
p. 2598-2599
|
article
|
| 37 |
Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter]
|
Eizirik, Decio L.
|
|
|
67 |
Suppl 1 |
p. 2600-2602
|
article
|
| 38 |
Comments on the notion of false positivity in measurements of autoantibodies
|
Grill, Valdemar
|
|
|
67 |
Suppl 1 |
p. 567-568
|
article
|
| 39 |
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care
|
Fadini, Gian Paolo
|
|
|
67 |
Suppl 1 |
p. 2585-2597
|
article
|
| 40 |
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
|
Kim, Ji Yoon
|
|
|
67 |
Suppl 1 |
p. 1235-1244
|
article
|
| 41 |
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
|
Phillip, Moshe
|
|
|
67 |
Suppl 1 |
p. 1731-1759
|
article
|
| 42 |
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
|
Jancev, Milena
|
|
|
67 |
Suppl 1 |
p. 798-810
|
article
|
| 43 |
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial
|
Kim, Ji Yoon
|
|
|
67 |
Suppl 1 |
p. 1223-1234
|
article
|
| 44 |
Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes
|
McNeilly, Alison D.
|
|
|
67 |
Suppl 1 |
p. 1724
|
article
|
| 45 |
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes
|
Phillip, Moshe
|
|
|
67 |
Suppl 1 |
p. 2012-2014
|
article
|
| 46 |
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
|
Blüher, Matthias
|
|
|
67 |
Suppl 1 |
p. 758
|
article
|
| 47 |
Correction to: Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice
|
Xi, Yannan
|
|
|
67 |
Suppl 1 |
p. 215
|
article
|
| 48 |
Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium
|
Visser, Margaretha M.
|
|
|
67 |
Suppl 1 |
p. 650-662
|
article
|
| 49 |
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention
|
Pouwer, Frans
|
|
|
67 |
Suppl 1 |
p. 954-955
|
article
|
| 50 |
Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors
|
Aldous, Noura
|
|
|
67 |
Suppl 1 |
p. 2786-2803
|
article
|
| 51 |
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study
|
Winther-Sørensen, Marie
|
|
|
67 |
Suppl 1 |
p. 1602-1615
|
article
|
| 52 |
Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL
|
Carlton, Jill
|
|
|
67 |
Suppl 1 |
p. 1536-1551
|
article
|
| 53 |
Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges
|
Mackenzie, Scott C.
|
|
|
67 |
Suppl 1 |
p. 223-235
|
article
|
| 54 |
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
|
Holt, Richard I. G.
|
|
|
67 |
Suppl 1 |
p. 1168-1180
|
article
|
| 55 |
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study
|
Thomson, Rebecca L.
|
|
|
67 |
Suppl 1 |
p. 2420-2432
|
article
|
| 56 |
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
|
Sterner Isaksson, Sofia
|
|
|
67 |
Suppl 1 |
p. 1517-1526
|
article
|
| 57 |
Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults
|
Haslam, Danielle E.
|
|
|
67 |
Suppl 1 |
p. 1838-1852
|
article
|
| 58 |
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
|
Blüher, Matthias
|
|
|
67 |
Suppl 1 |
p. 470-482
|
article
|
| 59 |
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
|
Corpeleijn, Willemijn E.
|
|
|
67 |
Suppl 1 |
p. 19-26
|
article
|
| 60 |
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
|
Hummel, Sandra
|
|
|
67 |
Suppl 1 |
p. 670-678
|
article
|
| 61 |
Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial
|
Tricò, Domenico
|
|
|
67 |
Suppl 1 |
p. 263-274
|
article
|
| 62 |
Editorial Expression of Concern: Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial
|
Asemi, Zatollah
|
|
|
67 |
Suppl 1 |
p. 759-760
|
article
|
| 63 |
Effectiveness and safety of empagliflozin: final results from the EMPRISE study
|
Htoo, Phyo T.
|
|
|
67 |
Suppl 1 |
p. 1328-1342
|
article
|
| 64 |
Effects of maternal type 1 diabetes and confounding factors on neonatal microbiomes
|
Gajecka, Marzena
|
|
|
67 |
Suppl 1 |
p. 312-326
|
article
|
| 65 |
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial
|
Vernstrøm, Liv
|
|
|
67 |
Suppl 1 |
p. 2175-2187
|
article
|
| 66 |
Effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease
|
Lin, Donna S.-H.
|
|
|
67 |
Suppl 1 |
p. 2459-2470
|
article
|
| 67 |
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial
|
Wang, Weiqing
|
|
|
67 |
Suppl 1 |
p. 1783-1799
|
article
|
| 68 |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
|
Ji, Linong
|
|
|
67 |
Suppl 1 |
p. 1800-1816
|
article
|
| 69 |
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment
|
Su, Mengqi
|
|
|
67 |
Suppl 1 |
p. 850-863
|
article
|
| 70 |
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes
|
Smith, Kieran
|
|
|
67 |
Suppl 1 |
p. 2555-2567
|
article
|
| 71 |
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials
|
Mellor, Joseph
|
|
|
67 |
Suppl 1 |
p. 2210-2224
|
article
|
| 72 |
Exercise-induced increase in muscle insulin sensitivity in men is amplified when assessed using a meal test
|
Voldstedlund, Christian T.
|
|
|
67 |
Suppl 1 |
p. 1386-1398
|
article
|
| 73 |
Feasibility of prevention of type 2 diabetes in low- and middle-income countries
|
Kengne, Andre P.
|
|
|
67 |
Suppl 1 |
p. 763-772
|
article
|
| 74 |
Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study
|
Elliott, Jackie
|
|
|
67 |
Suppl 1 |
p. 190-198
|
article
|
| 75 |
Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes
|
Tuomela, Karoliina
|
|
|
67 |
Suppl 1 |
p. 611-622
|
article
|
| 76 |
Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study
|
Heikkilä, Tea E.
|
|
|
67 |
Suppl 1 |
p. 2667-2677
|
article
|
| 77 |
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts
|
Adebekun, Jolade
|
|
|
67 |
Suppl 1 |
p. 2518-2529
|
article
|
| 78 |
Genetics of glucose homeostasis in pregnancy and postpartum
|
Lowe, William L.
|
|
|
67 |
Suppl 1 |
p. 2726-2739
|
article
|
| 79 |
Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits
|
Zhen, Jianxin
|
|
|
67 |
Suppl 1 |
p. 703-713
|
article
|
| 80 |
Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden
|
Metsälä, Johanna
|
|
|
67 |
Suppl 1 |
p. 1315-1327
|
article
|
| 81 |
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
|
Gandasi, Nikhil R.
|
|
|
67 |
Suppl 1 |
p. 528-546
|
article
|
| 82 |
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap
|
Chilunga, Felix P.
|
|
|
67 |
Suppl 1 |
p. 2833-2835
|
article
|
| 83 |
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy
|
Dhanapalaratnam, Roshan
|
|
|
67 |
Suppl 1 |
p. 561-566
|
article
|
| 84 |
Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes
|
Zhong, Ting
|
|
|
67 |
Suppl 1 |
p. 42-51
|
article
|
| 85 |
Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes
|
Donovan, Lois E.
|
|
|
67 |
Suppl 1 |
p. 2154-2159
|
article
|
| 86 |
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study
|
Vatanen, Tommi
|
|
|
67 |
Suppl 1 |
p. 1930-1942
|
article
|
| 87 |
Habitual carbohydrate intake is not correlated with circulating β-hydroxybutyrate levels in pregnant women with overweight and obesity at 28 weeks' gestation
|
Tanner, Helen L.
|
|
|
67 |
Suppl 1 |
p. 346-355
|
article
|
| 88 |
HbA1c variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes
|
Muthukumar, Ananya
|
|
|
67 |
Suppl 1 |
p. 1955-1961
|
article
|
| 89 |
Heterogeneity of glycaemic phenotypes in type 1 diabetes
|
Fagherazzi, Guy
|
|
|
67 |
Suppl 1 |
p. 1567-1581
|
article
|
| 90 |
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation
|
Yamaguchi, Muneo
|
|
|
67 |
Suppl 1 |
p. 2329-2345
|
article
|
| 91 |
Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes
|
de Wit, Douwe F.
|
|
|
67 |
Suppl 1 |
p. 2199-2209
|
article
|
| 92 |
High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study
|
Farrell, Catriona M.
|
|
|
67 |
Suppl 1 |
p. 392-402
|
article
|
| 93 |
HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives
|
Petrelli, Alessandra
|
|
|
67 |
Suppl 1 |
p. 290-300
|
article
|
| 94 |
Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies
|
Emanuelsson, Frida
|
|
|
67 |
Suppl 1 |
p. 301-311
|
article
|
| 95 |
Identification and validation of gestational diabetes subgroups by data-driven cluster analysis
|
Salvatori, Benedetta
|
|
|
67 |
Suppl 1 |
p. 1552-1566
|
article
|
| 96 |
Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations
|
Liu, Shuai
|
|
|
67 |
Suppl 1 |
p. 2754-2770
|
article
|
| 97 |
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis
|
You, Lu
|
|
|
67 |
Suppl 1 |
p. 2507-2517
|
article
|
| 98 |
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study
|
Xie, Cong
|
|
|
67 |
Suppl 1 |
p. 1260-1270
|
article
|
| 99 |
Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial
|
van den Burg, Elske L.
|
|
|
67 |
Suppl 1 |
p. 1245-1259
|
article
|
| 100 |
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes
|
Coomans de Brachène, Alexandra
|
|
|
67 |
Suppl 1 |
p. 908-927
|
article
|
| 101 |
Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case–control study
|
Lundgaard, Agnete T.
|
|
|
67 |
Suppl 1 |
p. 2289-2303
|
article
|
| 102 |
Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans
|
Xiao, Qian
|
|
|
67 |
Suppl 1 |
p. 1853-1864
|
article
|
| 103 |
Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality
|
Hansen, Aleksander L.
|
|
|
67 |
Suppl 1 |
p. 1616-1629
|
article
|
| 104 |
Machine learning-based reproducible prediction of type 2 diabetes subtypes
|
Tanabe, Hayato
|
|
|
67 |
Suppl 1 |
p. 2446-2458
|
article
|
| 105 |
Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden
|
Kennedy, Beatrice
|
|
|
67 |
Suppl 1 |
p. 1828-1837
|
article
|
| 106 |
Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018
|
Regnault, Nolwenn
|
|
|
67 |
Suppl 1 |
p. 516-527
|
article
|
| 107 |
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals
|
She, Rui
|
|
|
67 |
Suppl 1 |
p. 1095-1106
|
article
|
| 108 |
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
|
Lavens, Astrid
|
|
|
67 |
Suppl 1 |
p. 2678-2690
|
article
|
| 109 |
Metabolomic and genetic architecture of gestational diabetes subtypes
|
Lee, Kristen
|
|
|
67 |
Suppl 1 |
p. 895-907
|
article
|
| 110 |
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
|
Savarese, Gianluigi
|
|
|
67 |
Suppl 1 |
p. 246-262
|
article
|
| 111 |
Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes
|
Zhang, Juan
|
|
|
67 |
Suppl 1 |
p. 1698-1713
|
article
|
| 112 |
Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte–endothelial interactions
|
Luna-Marco, Clara
|
|
|
67 |
Suppl 1 |
p. 2316-2328
|
article
|
| 113 |
Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management
|
Holman, Naomi
|
|
|
67 |
Suppl 1 |
p. 2691-2701
|
article
|
| 114 |
MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial
|
Heianza, Yoriko
|
|
|
67 |
Suppl 1 |
p. 506-515
|
article
|
| 115 |
New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus
|
Van der Schueren, Bart
|
|
|
67 |
Suppl 1 |
p. 1159-1162
|
article
|
| 116 |
No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts
|
Lund-Blix, Nicolai A.
|
|
|
67 |
Suppl 1 |
p. 1023-1028
|
article
|
| 117 |
Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus
|
Denicolò, Sara
|
|
|
67 |
Suppl 1 |
p. 1283-1294
|
article
|
| 118 |
Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes
|
Vyakaranam, Achyut Ram
|
|
|
67 |
Suppl 1 |
p. 199-208
|
article
|
| 119 |
Non-invasive quantification of stem cell-derived islet graft size and composition
|
Lithovius, Väinö
|
|
|
67 |
Suppl 1 |
p. 1912-1929
|
article
|
| 120 |
Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases
|
Wat, Lianna W.
|
|
|
67 |
Suppl 1 |
p. 2626-2636
|
article
|
| 121 |
Novel time-resolved reporter mouse reveals spatial and transcriptional heterogeneity during alpha cell differentiation
|
Himuro, Miwa
|
|
|
67 |
Suppl 1 |
p. 156-169
|
article
|
| 122 |
NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function
|
Baumel-Alterzon, Sharon
|
|
|
67 |
Suppl 1 |
p. 547-560
|
article
|
| 123 |
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
|
Trevisan, Roberto
|
|
|
67 |
Suppl 1 |
p. 1480-1492
|
article
|
| 124 |
Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial
|
Drenthen, Linda C. A.
|
|
|
67 |
Suppl 1 |
p. 52-61
|
article
|
| 125 |
Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle
|
Zemski Berry, Karin A.
|
|
|
67 |
Suppl 1 |
p. 2819-2832
|
article
|
| 126 |
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq
|
Amaratunga, Shenali A.
|
|
|
67 |
Suppl 1 |
p. 113-123
|
article
|
| 127 |
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas
|
Meulebrouck, Sarah
|
|
|
67 |
Suppl 1 |
p. 327-332
|
article
|
| 128 |
Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses
|
Ehrmann, Dominic
|
|
|
67 |
Suppl 1 |
p. 2433-2445
|
article
|
| 129 |
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans
|
Wreven, Elise
|
|
|
67 |
Suppl 1 |
p. 1877-1896
|
article
|
| 130 |
Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study
|
Raubenheimer, Peter J.
|
|
|
67 |
Suppl 1 |
p. 494-505
|
article
|
| 131 |
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
|
Cardoso, Pedro
|
|
|
67 |
Suppl 1 |
p. 822-836
|
article
|
| 132 |
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities
|
Sacco, Simona
|
|
|
67 |
Suppl 1 |
p. 1192-1205
|
article
|
| 133 |
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children
|
Bruzzaniti, Sara
|
|
|
67 |
Suppl 1 |
p. 714-723
|
article
|
| 134 |
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers
|
Zhao, Lue Ping
|
|
|
67 |
Suppl 1 |
p. 2481-2493
|
article
|
| 135 |
QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts
|
Garcia, Rodrigue
|
|
|
67 |
Suppl 1 |
p. 641-649
|
article
|
| 136 |
Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes
|
Apaolaza, Paola S.
|
|
|
67 |
Suppl 1 |
p. 2771-2785
|
article
|
| 137 |
Relationship of device measured physical activity type and posture with cardiometabolic health markers: pooled dose–response associations from the Prospective Physical Activity, Sitting and Sleep Consortium
|
Ahmadi, Matthew N.
|
|
|
67 |
Suppl 1 |
p. 1051-1065
|
article
|
| 138 |
Remission of type 2 diabetes: always more questions, but enough answers for action
|
Rothberg, Amy
|
|
|
67 |
Suppl 1 |
p. 602-610
|
article
|
| 139 |
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials
|
Mellor, Joseph
|
|
|
67 |
Suppl 1 |
p. 1588-1601
|
article
|
| 140 |
Risk factors for Charcot foot development in individuals with diabetes mellitus
|
Tsatsaris, Georgios
|
|
|
67 |
Suppl 1 |
p. 2702-2710
|
article
|
| 141 |
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
|
Eleftheriadou, Aikaterini
|
|
|
67 |
Suppl 1 |
p. 1271-1282
|
article
|
| 142 |
RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine
|
Miskelly, Michael G.
|
|
|
67 |
Suppl 1 |
p. 356-370
|
article
|
| 143 |
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach
|
Güdemann, Laura M.
|
|
|
67 |
Suppl 1 |
p. 1817-1827
|
article
|
| 144 |
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial
|
Hyöty, Heikki
|
|
|
67 |
Suppl 1 |
p. 811-821
|
article
|
| 145 |
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells
|
Visa, Montse
|
|
|
67 |
Suppl 1 |
p. 1663-1682
|
article
|
| 146 |
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
|
Sánchez-Hernández, Rosa M.
|
|
|
67 |
Suppl 1 |
p. 952-953
|
article
|
| 147 |
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sánchez‑Hernández and Wägner [letter]
|
Corpeleijn, Willemijn E.
|
|
|
67 |
Suppl 1 |
p. 1448-1449
|
article
|
| 148 |
Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α
|
Liu, Beibei
|
|
|
67 |
Suppl 1 |
p. 724-737
|
article
|
| 149 |
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
|
Karagiannis, Thomas
|
|
|
67 |
Suppl 1 |
p. 1206-1222
|
article
|
| 150 |
Surveillance of the liver in type 2 diabetes: important but unfeasible?
|
Qadri, Sami
|
|
|
67 |
Suppl 1 |
p. 961-973
|
article
|
| 151 |
Technology advances in diabetes pregnancy: right technology, right person, right time
|
McLean, Anna
|
|
|
67 |
Suppl 1 |
p. 2103-2113
|
article
|
| 152 |
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study
|
De Meulemeester, Jolien
|
|
|
67 |
Suppl 1 |
p. 1527-1535
|
article
|
| 153 |
The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
|
Elbarbary, Nancy S.
|
|
|
67 |
Suppl 1 |
p. 2637-2649
|
article
|
| 154 |
The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum
|
Byndloss, Mariana
|
|
|
67 |
Suppl 1 |
p. 1760-1782
|
article
|
| 155 |
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app
|
Søholm, Uffe
|
|
|
67 |
Suppl 1 |
p. 2160-2174
|
article
|
| 156 |
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults
|
Marcovecchio, M. Loredana
|
|
|
67 |
Suppl 1 |
p. 995-1008
|
article
|
| 157 |
The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes
|
Groegler, Jason
|
|
|
67 |
Suppl 1 |
p. 1507-1516
|
article
|
| 158 |
The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity
|
Esser, Nathalie
|
|
|
67 |
Suppl 1 |
p. 1897-1911
|
article
|
| 159 |
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes
|
Taylor, Guy S.
|
|
|
67 |
Suppl 1 |
p. 1413-1428
|
article
|
| 160 |
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)
|
Corbin, Laura J.
|
|
|
67 |
Suppl 1 |
p. 74-87
|
article
|
| 161 |
The role of automated insulin delivery technology in diabetes
|
Boughton, Charlotte K.
|
|
|
67 |
Suppl 1 |
p. 2034-2044
|
article
|
| 162 |
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo
|
Davidson, Rebecca K.
|
|
|
67 |
Suppl 1 |
p. 2275-2288
|
article
|
| 163 |
The use of technology in type 2 diabetes and prediabetes: a narrative review
|
Liarakos, Alexandros L.
|
|
|
67 |
Suppl 1 |
p. 2059-2074
|
article
|
| 164 |
Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring
|
Wang, Yaxin
|
|
|
67 |
Suppl 1 |
p. 1295-1303
|
article
|
| 165 |
Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population
|
Donnelly, Louise A.
|
|
|
67 |
Suppl 1 |
p. 2236-2245
|
article
|
| 166 |
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes
|
Li, Xinyu
|
|
|
67 |
Suppl 1 |
p. 1343-1355
|
article
|
| 167 |
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial
|
Kornum, Ditte S.
|
|
|
67 |
Suppl 1 |
p. 1122-1137
|
article
|
| 168 |
tRNA-derived fragments in T lymphocyte–beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice
|
Brozzi, Flora
|
|
|
67 |
Suppl 1 |
p. 2260-2274
|
article
|
| 169 |
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review
|
Ahmed, Rabeeyah
|
|
|
67 |
Suppl 1 |
p. 443-458
|
article
|
| 170 |
Type 2 diabetes and succinate: unmasking an age-old molecule
|
Fernández-Veledo, Sonia
|
|
|
67 |
Suppl 1 |
p. 430-442
|
article
|
| 171 |
Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort
|
Du, Shutong
|
|
|
67 |
Suppl 1 |
p. 2225-2235
|
article
|
| 172 |
Up Front
|
|
|
|
67 |
Suppl 1 |
p. 1453-1454
|
article
|
| 173 |
Use of diabetes technology in children
|
Schoelwer, Melissa J.
|
|
|
67 |
Suppl 1 |
p. 2075-2084
|
article
|
| 174 |
Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes
|
Rollin, Francois G.
|
|
|
67 |
Suppl 1 |
p. 211-212
|
article
|
| 175 |
Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease
|
Haukka, Jani K.
|
|
|
67 |
Suppl 1 |
p. 2494-2506
|
article
|
| 176 |
Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1
|
Wu, Yao
|
|
|
67 |
Suppl 1 |
p. 2346-2366
|
article
|
Journal description